(Q48851886)

16 February 2018

title

High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease. (English)

1 reference

16 February 2018

1 reference

1 reference

7

1 reference

16 February 2018

Dorothee P. Auer

8

1 reference

16 February 2018

Penny Gowland

9

1 reference

16 February 2018

Andrew M Peters

object named as

Andrew M Peters

6

0 references

author name string

Ashley K Lotfipour

1

1 reference

16 February 2018

Samuel Wharton

2

1 reference

16 February 2018

Stefan T Schwarz

3

1 reference

16 February 2018

V Gontu

4

1 reference

16 February 2018

Andreas Schäfer

5

1 reference

16 February 2018

Nin P S Bajaj

10

1 reference

16 February 2018

publication date

10 October 2011

1 reference

16 February 2018

Journal of Magnetic Resonance Imaging

published in

1 reference

16 February 2018

volume

35

1 reference

16 February 2018

issue

1

1 reference

16 February 2018

page(s)

48-55

1 reference

16 February 2018

Iron and oxygen radicals in brain

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Case control study of diffusion tensor imaging in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

MRI assessment of basal ganglia iron deposition in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson??s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

High-field MRI of brain cortical substructure based on signal phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Using magnetic field simulation to study susceptibility-related phase contrast in gradient echo MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Whole-brain susceptibility mapping at high field: a comparison of multiple- and single-orientation methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Susceptibility weighted imaging (SWI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Susceptibility mapping in the human brain using threshold-based k-space division.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

High-field magnetic resonance imaging of brain iron: birth of a biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Imaging iron stores in the brain using magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Individual dopaminergic neurons show raised iron levels in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Magnetic investigations of human mesencephalic neuromelanin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Modifications of the iron-neuromelanin system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Iron and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

T1 and T2 of ferritin solutions: effect of loading factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Magnetic iron compounds in the human brain: a comparison of tumour and hippocampal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

Monoamine neurons in the human brain stem: anatomy, magnetic resonance imaging findings, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22752

21 January 2018

Identifiers

DOI

10.1002/JMRI.22752

1 reference

16 February 2018

PubMed ID

21987471

1 reference

16 February 2018